Dried Blood Spots (DBS): A suitable alternative to using whole blood samples for diagnostic testing of visceral leishmaniasis in the post-elimination era

PLoS Negl Trop Dis. 2023 Oct 20;17(10):e0011680. doi: 10.1371/journal.pntd.0011680. eCollection 2023 Oct.

Abstract

Background: Serum or whole blood collection, processing, transport and storage still present significant challenges in low resource settings where mass surveillance is required to sustain disease elimination. Therefore, in this study, we explored the diagnostic efficacy of dried blood spots (DBS) as a minimally invasive and potentially cost-effective alternative sampling technique to whole blood sampling procedures for subsequent detection of Leishmania donovani antibodies or DNA.

Methodology and principal findings: Archived serum, DNA samples from whole blood of visceral leishmaniasis (VL) cases and healthy controls, and DBS from corresponding cases and controls, were used. Both molecular and serological assays were optimized to detect L. donovani antibodies or DNA in DBS elute and results were compared against those obtained with whole blood. Serological assays (both rK28 ELISA and rK39 ELISA) of DBS samples showed sensitivity and specificity of 100% and had excellent agreement with results from whole blood samples (kappa value ranged from 0.98-1). Bland-Altman analysis of OD values from rK28-ELISA with DBS elute and patients' serum showed an excellent agreement (ICC = 0.9) whereas a good agreement (ICC = 0.8) was observed in the case of rK39-ELISA. However, qPCR and RPA of DBS samples had a diminished sensitivity of 76% and 68%, respectively, and poor agreement was observed with the whole blood samples.

Conclusion: Our results demonstrate that DBS offer excellent diagnostic efficiency for serological assays and represent a viable alternative to whole blood sampling procedures.

MeSH terms

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • DNA
  • Diagnostic Techniques and Procedures
  • Dried Blood Spot Testing / methods
  • Humans
  • Leishmaniasis, Visceral* / diagnosis
  • Leishmaniasis, Visceral* / epidemiology
  • Sensitivity and Specificity

Substances

  • Antigens, Protozoan
  • Antibodies, Protozoan
  • DNA

Grants and funding

The funding was granted by the Swedish International Development Cooperation Agency (Sida,GR-01455), Sweden and Rainy Day Grant Fund under ‘Young investigator’s award’, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) to PG. The authors alone are responsible for the views expressed in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.